Literature DB >> 16195982

Effects of acute salbutamol intake during a Wingate test.

K Collomp1, B Le Panse, H Portier, A-M Lecoq, C Jaffre, H Beaupied, O Richard, L Benhamou, D Courteix, J De Ceaurriz.   

Abstract

To investigate the impact of acute salbutamol intake on performance and selected hormonal and metabolic variables during supramaximal exercise, 13 recreational male athletes performed two 30-second Wingate tests after either placebo (PLA, lactose) or salbutamol (SAL, 4 mg) oral administration, according to a double-blind and randomized protocol. Blood samples collected at rest, end of the Wingate test, recovery (5, 10, 15 min) were tested for growth hormone (GH), insulin (INS), blood glucose (GLU), and lactate determination. We found the peak and mean power performed significantly increased after SAL vs. PLA (PPSAL: 896 +/- 46; PPPLA: 819 +/- 57 W; MPSAL: 585 +/- 27; MPPLA: 534 +/- 35 W, p < 0.05), whereas no change was observed in the fatigue index. Blood glucose and INS were significantly increased by SAL at rest, at the end of the Wingate test, and during the 5 first minutes of recovery (p < 0.05). Plasma GH was significantly decreased by SAL (p < 0.05) during the recovery whereas end-exercise and recovery blood lactate tended but were not significantly increased after SAL vs. PLA. From these data, acute salbutamol intake at therapeutical dosage did appear to improve peak power and mean power during a supramaximal exercise, but the mechanisms involved need further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195982     DOI: 10.1055/s-2004-821223

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  17 in total

1.  Acute supra-therapeutic oral terbutaline administration has no ergogenic effect in non-asthmatic athletes.

Authors:  Anthony M J Sanchez; Fabio Borrani; Marie Amélie Le Fur; Anais Le Mieux; Virgile Lecoultre; Guillaume Py; Christophe Gernigon; Katia Collomp; Robin Candau
Journal:  Eur J Appl Physiol       Date:  2012-07-06       Impact factor: 3.078

Review 2.  β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Babette M Pluim; Olivier de Hon; J Bart Staal; Jacqueline Limpens; Harm Kuipers; Shelley E Overbeek; Aeilko H Zwinderman; Rob J P M Scholten
Journal:  Sports Med       Date:  2011-01-01       Impact factor: 11.136

Review 3.  β-Adrenergic modulation of skeletal muscle contraction: key role of excitation-contraction coupling.

Authors:  Simeon P Cairns; Fabio Borrani
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

Review 4.  Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?

Authors:  Wilfried Kindermann
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men.

Authors:  Morten Hostrup; Anders Kalsen; Jens Bangsbo; Peter Hemmersbach; Sebastian Karlsson; Vibeke Backer
Journal:  Eur J Appl Physiol       Date:  2014-08-12       Impact factor: 3.078

6.  β2-adrenergic stimulation enhances Ca2+ release and contractile properties of skeletal muscles, and counteracts exercise-induced reductions in Na+-K+-ATPase Vmax in trained men.

Authors:  M Hostrup; A Kalsen; N Ortenblad; C Juel; K Mørch; S Rzeppa; S Karlsson; V Backer; J Bangsbo
Journal:  J Physiol       Date:  2014-10-24       Impact factor: 5.182

7.  Salbutamol effects on systemic potassium dynamics during and following intense continuous and intermittent exercise.

Authors:  Muath M Altarawneh; Aaron Petersen; Robert Smith; David M Rouffet; Francois Billaut; Ben D Perry; Victoria L Wyckelsma; Antony Tobin; Michael J McKenna
Journal:  Eur J Appl Physiol       Date:  2016-10-22       Impact factor: 3.078

8.  Effect of acute and short-term oral salbutamol treatments on maximal power output in non-asthmatic athletes.

Authors:  Anthony M J Sanchez; Katia Collomp; Juliette Carra; Fabio Borrani; Olivier Coste; Christian Préfaut; Robin Candau
Journal:  Eur J Appl Physiol       Date:  2012-01-10       Impact factor: 3.078

9.  Salbutamol intake and substrate oxidation during submaximal exercise.

Authors:  A Arlettaz; B Le Panse; H Portier; A-M Lecoq; R Thomasson; J De Ceaurriz; K Collomp
Journal:  Eur J Appl Physiol       Date:  2008-10-17       Impact factor: 3.078

10.  Salbutamol exhibits androgenic activity in vitro.

Authors:  André O von Bueren; Risheng Ma; Margret Schlumpf; Walter Lichtensteiger
Journal:  Br J Sports Med       Date:  2007-05-17       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.